These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Benziodarone in the basic treatment of gout]. Ryckewaert A, Puel M, Kuntz D. Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688 [No Abstract] [Full Text] [Related]
5. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone]. Mugler A. Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166 [No Abstract] [Full Text] [Related]
9. [Changes in the serum concentration of uric acid under the effect of benzbromaronum]. Mertz DP. Munch Med Wochenschr; 1969 Feb 28; 111(9):491-5. PubMed ID: 5818966 [No Abstract] [Full Text] [Related]
12. [Treatment and prevention of gout with uricosuric agents]. May P, Lux B. Med Monatsschr Pharm; 1978 May 28; 1(5):147-50. PubMed ID: 756510 [No Abstract] [Full Text] [Related]
13. [Uninterrupted therapy of hyperuricemia and gout]. Schilling F. Reumatizam; 1971 May 28; 18(3):79-82. PubMed ID: 5097291 [No Abstract] [Full Text] [Related]
14. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear. Wong ML. N Z Med J; 2005 Jun 24; 118(1217):U1533. PubMed ID: 15980907 [No Abstract] [Full Text] [Related]
15. [Treatment of gout by inhibitors of uric acid synthesis]. Delbarre F. Acquis Med Recent; 1970 Jun 24; ():145-66. PubMed ID: 5526170 [No Abstract] [Full Text] [Related]